Transcept's NDA Intermission For Insomnia Drug Intermezzo Set To End In First Quarter

Results from a driving impairment study strengthen the case for approval, the company says.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet